BENEFICIAL EFFECT OF GROWTH-HORMONE ON ATHEROGENIC RISK IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY

被引：26

作者：

KOHNO, H

UEYAMA, N

YANAI, S

UKAJI, K

HONDA, S

机构：

来源：

JOURNAL OF PEDIATRICS | 1995年 / 126卷 / 06期

关键词：

D O I：

10.1016/S0022-3476(95)70220-2

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

We studied changes in the atherogenic index (total cholesterol + high-density lipoprotein cholesterol) in 12 prepubertal boys with growth hormone (GH) deficiency during 9 months of GH treatment. High-density lipoprotein cholesterol level increased until 5 months without significant changes in total cholesterol level; thus GH therapy may be beneficial in reducing the atherogenic index in boys with GH deficiency.

引用

收藏

页码：953 / 955

页数：3

相关论文

共 13 条

[1] GROWTH-HORMONE INDUCED CHANGES IN POSTHEPARIN PLASMA-LIPOPROTEIN LIPASE AND HEPATIC TRIGLYCERIDE LIPASE ACTIVITIES [J].

ASAYAMA, K ;

AMEMIYA, S ;

KUSANO, S ;

KATO, K .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (02) :129-131

[2] SUMMARY ESTIMATES OF CHOLESTEROL USED TO PREDICT CORONARY HEART-DISEASE [J].

CASTELLI, WP ;

ABBOTT, RD ;

MCNAMARA, PM .

CIRCULATION, 1983, 67 (04) :730-734

[3] BODY COMPOSITION CHANGES IN CHILDREN RECEIVING HUMAN GROWTH-HORMONE [J].

COLLIPP, PJ ;

CURTI, V ;

THOMAS, J ;

SHARMA, RK ;

MADDAIAH, VT ;

COHN, SH .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1973, 22 (04) :589-595

[4] GROWTH-HORMONE TREATMENT OF GROWTH HORMONE-DEFICIENT ADULTS RESULTS IN A MARKED INCREASE IN LP(A) AND HDL CHOLESTEROL CONCENTRATIONS [J].

EDEN, S ;

WIKLUND, O ;

OSCARSSON, J ;

ROSEN, T ;

BENGTSSON, BA .

ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02) :296-301

[5] VALIDITY OF BIOELECTRIC IMPEDANCE FOR BODY-COMPOSITION ASSESSMENT IN CHILDREN [J].

HOUTKOOPER, LB ;

LOHMAN, TG ;

GOING, SB ;

HALL, MC .

JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (02) :814-821

[6] EFFECT OF GROWTH-HORMONE REPLACEMENT ON DEVELOPMENT OF HYPOTHYROIDISM AND HYPERLIPIDEMIA [J].

LAFRANCHI, S ;

HANNA, CE ;

ILLINGWORTH, DR .

JOURNAL OF PEDIATRICS, 1985, 106 (04) :588-593

[7] LONG-TERM FOLLOW-UP OF HYPOPITUITARY PATIENTS TREATED WITH HUMAN GROWTH-HORMONE [J].

LIBBER, SM ;

PLOTNICK, LP ;

JOHANSON, AJ ;

BLIZZARD, RM ;

KWITEROVICH, PO ;

MIGEON, CJ .

MEDICINE, 1990, 69 (01) :46-55

[8] IMPACT OF HUMAN GROWTH-HORMONE ON PLASMA-LIPOPROTEIN CONCENTRATIONS [J].

MOLLER, A ;

RASMUSSEN, LM ;

THUESEN, L ;

CHRISTIANSEN, JS .

HORMONE AND METABOLIC RESEARCH, 1989, 21 (04) :207-209

[9] PREMATURE MORTALITY DUE TO CARDIOVASCULAR-DISEASE IN HYPOPITUITARISM [J].

ROSEN, T ;

BENGTSSON, BA .

LANCET, 1990, 336 (8710) :285-288

[10] EFFECTS OF SYSTEMIC GROWTH-HORMONE (GH) ADMINISTRATION ON REGIONAL ADIPOSE-TISSUE DISTRIBUTION AND METABOLISM IN GH-DEFICIENT CHILDREN [J].

ROSENBAUM, M ;

GERTNER, JM ;

LEIBEL, RL .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (06) :1274-1281